AMPIO PHARMACEUTICALS INC's ticker is AMPE and the CUSIP is 03209T109. A total of 123 filers reported holding AMPIO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 10,890 | +39.8% | 0.00% | – |
| Q2 2022 | $1,000 | -75.0% | 7,790 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | 0.0% | 7,790 | 0.0% | 0.00% | – |
| Q4 2021 | $4,000 | -69.2% | 7,790 | 0.0% | 0.00% | – |
| Q3 2021 | $13,000 | 0.0% | 7,790 | 0.0% | 0.00% | – |
| Q2 2021 | $13,000 | -23.5% | 7,790 | -20.4% | 0.00% | – |
| Q1 2021 | $17,000 | +41.7% | 9,790 | +25.7% | 0.00% | – |
| Q4 2020 | $12,000 | +71.4% | 7,790 | 0.0% | 0.00% | – |
| Q3 2020 | $7,000 | +40.0% | 7,790 | 0.0% | 0.00% | – |
| Q2 2020 | $5,000 | +66.7% | 7,790 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | -40.0% | 7,790 | 0.0% | 0.00% | – |
| Q4 2019 | $5,000 | +25.0% | 7,790 | 0.0% | 0.00% | – |
| Q3 2019 | $4,000 | +33.3% | 7,790 | 0.0% | 0.00% | – |
| Q2 2019 | $3,000 | -25.0% | 7,790 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | +33.3% | 7,790 | 0.0% | 0.00% | – |
| Q4 2018 | $3,000 | – | 7,790 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 4,262,409 | $2,430,000 | 5.07% |
| CVI Holdings, LLC | 5,171,896 | $2,948,000 | 0.20% |
| PRIVATE CAPITAL MANAGEMENT LLC | 937,237 | $534,000 | 0.18% |
| CVA Family Office, LLC | 1,137,920 | $649,000 | 0.16% |
| ACT CAPITAL MANAGEMENT, LLC | 291,500 | $166,000 | 0.12% |
| Cypress Capital Management LLC (WY) | 196,775 | $112,000 | 0.09% |
| Willis Investment Counsel | 2,181,840 | $1,244,000 | 0.06% |
| NTB Financial Corp | 146,100 | $83,000 | 0.06% |
| Helen Stephens Group, LLC | 117,222 | $67,000 | 0.05% |
| SRS Capital Advisors, Inc. | 629,172 | $359,000 | 0.05% |